Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016


  • Products Id :- GDHC3699CTIDB
  • |
  • Pages: 393
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, ''Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016'' provides an overview of Systemic Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Systemic Lupus Erythematosus Therapeutics Clinical Trials 28

Prominent Drugs 30

Latest Clinical Trials News on Systemic Lupus Erythematosus 31

Aug 03, 2016: Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod 31

Jul 19, 2016: Kadmon Data Published in Science Signaling Show ROCK2 Signaling as a Key Modulator of T Follicular Helper Cell Function in Autoimmune Diseases 31

Jun 28, 2016: Anthera Provides Clinical Program Update for Blisibimod 32

Jun 20, 2016: Dalazatide as a Potential Immunotherapy for Lupus to be Presented at Immunology Conference 33

Jun 09, 2016: Mallinckrodt Presents New Data from 44-Week Open Label Extension Of Company-Sponsored H.P. Acthar Gel Trial in Lupus 33

Jun 08, 2016: New Phase III data shows greater treatment response with GSK's Benlysta (belimumab) vs placebo in patients with highly active SLE 34

Jun 08, 2016: UCB presents Phase 1 results for dapirolizumab pegol at the Annual European Congress of Rheumatology (EULAR 2016) 35

Jun 07, 2016: First European Patients Commence Dosing In Lupuzor's Pivotal Phase III Study 36

Jun 02, 2016: AbbVie Highlights on Venetoclax (ABT-199) at the Annual European Congress of Rheumatology (EULAR 2016) 36

Clinical Trial Profile Snapshots 37

Appendix 390

Abbreviations 390

Definitions 390

Research Methodology 391

Secondary Research 391

About GlobalData 392

Contact Us 392

Disclaimer 392

Source 393

List of Figures

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Systemic Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14

Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2016* 15

Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2016* 18

Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Systemic Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

GlobalData Methodology 391

List of Tables

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region, 2016* 6

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Systemic Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14

Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2016* 15

Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Systemic Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2016* 18

Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Systemic Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase, 2016* 21

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22

Systemic Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25

Systemic Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29

Systemic Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Plc

AstraZeneca Plc

F. Hoffmann-La Roche Ltd.

UCB S.A.

Bristol-Myers Squibb Company

Parexel International Corporation

Pfizer Inc.

Immunomedics, Inc.

Amgen Inc.

Biogen Inc

Systemic Lupus Erythematosus Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Systemic Lupus Erythematosus, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160050
Site License
USD 5000 INR 320100
Corporate User License
USD 7500 INR 480150

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com